Last synced on 18 April 2025 at 11:05 pm

Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator

Page Type
Product Code
Definition
Intended to enable clinicians to prepare an autologous skin cell suspension for application to burn injuries for use when autografting is indicated for definitive wound closure.
Physical State
The cell harvesting device is comprised of a bundled set of prep instruments, application tools, processing and carrier solutions packaged as a single, sterile, stand-alone, disposable (single-use kit). The device may include: (1) a processing unit for tissue incubation, rinsing, and filtering; (2) prep instruments: syringe, blunt needle, disposable scalper, spray nozzle, cell strainer; and (3) processing and carrier solutions: enzyme, sterile water, buffer. The cell suspension may be applied using a syringe outfitted with a spray nozzle.
Technical Method
Processing of a split-thickness skin sample using enzymatic and mechanical disaggregation to create a cell suspension.
Target Area
The device output cell suspension is applied to a burn injury wound bed and skin donor site that have been prepared by a healthcare provider to receive application of a skin autograft.
Review Panel
Hematology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QCZ to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator

Page Type
Product Code
Definition
Intended to enable clinicians to prepare an autologous skin cell suspension for application to burn injuries for use when autografting is indicated for definitive wound closure.
Physical State
The cell harvesting device is comprised of a bundled set of prep instruments, application tools, processing and carrier solutions packaged as a single, sterile, stand-alone, disposable (single-use kit). The device may include: (1) a processing unit for tissue incubation, rinsing, and filtering; (2) prep instruments: syringe, blunt needle, disposable scalper, spray nozzle, cell strainer; and (3) processing and carrier solutions: enzyme, sterile water, buffer. The cell suspension may be applied using a syringe outfitted with a spray nozzle.
Technical Method
Processing of a split-thickness skin sample using enzymatic and mechanical disaggregation to create a cell suspension.
Target Area
The device output cell suspension is applied to a burn injury wound bed and skin donor site that have been prepared by a healthcare provider to receive application of a skin autograft.
Review Panel
Hematology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QCZ to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.